Very late bioresorbable vascular scaffold thrombosis following discontinuation of antiplatelet therapy

Eur Heart J. 2015 Feb 7;36(6):393. doi: 10.1093/eurheartj/ehu419. Epub 2014 Oct 21.

Authors

Leo Timmers¹, Pieter R Stella¹, Pierfrancesco Agostoni²

Affiliations

¹ Department of Cardiology, University Medical Centre Utrecht, Room E04.201, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
² Department of Cardiology, University Medical Centre Utrecht, Room E04.201, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands p.agostoni@umcutrecht.nl.

PMID: 25336226
DOI: 10.1093/eurheartj/ehu419

No abstract available

Publication types

Case Reports
Video-Audio Media

MeSH terms

Absorbable Implants
Adenosine / analogs & derivatives
Adenosine / therapeutic use
Adult
Aspirin / therapeutic use
Blood Vessel Prosthesis
Clopidogrel
Graft Occlusion, Vascular / drug therapy
Graft Occlusion, Vascular / etiology*
Humans
Male
Myocardial Infarction / drug therapy
Myocardial Infarction / etiology*
Platelet Aggregation Inhibitors / therapeutic use
Purinergic P2Y Receptor Antagonists / therapeutic use
Stents
Ticagrelor
Ticlopidine / analogs & derivatives
Ticlopidine / therapeutic use
Tirofiban
Tissue Scaffolds
Tyrosine / analogs & derivatives
Tyrosine / therapeutic use

Substances

Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Tyrosine
Clopidogrel
Tirofiban
Ticagrelor
Adenosine
Ticlopidine
Aspirin